Level A· Stronger Clinical EvidenceSystematic ReviewPubMedOpen access

Oncologic safety of autologous fat grafting in head and neck cancer patients: A scoping review.

Correas MA., Ferrer GC., Martín-Moro JG., Soto MJ., Carretero JL.

Systematic Review with a reported sample of 116 on Face & Skin, published in Med Oral Patol Oral Cir Bucal (2026) — summary generated from the PubMed abstract.

Open my reading list
Level A· Stronger Clinical EvidenceEvidence level of this study

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Systematic Review
Journal
Med Oral Patol Oral Cir Bucal (2026)
Country
Spain
Reported sample size
116
Source database
PubMed
PMID
41273747
PMCID
PMC12983388
DOI
10.4317/medoral.27795

Abstract (original English)

Background Autologous fat grafting (AFG) has become increasingly used in reconstructive surgery due to its accessibility, safety, and regenerative potential. In head and neck cancer (HNC) patients, however, concerns remain regarding its oncologic safety, particularly due to the presence of adipose-derived stem cells (ASCs), which may theoretically influence tumor recurrence. This scoping review aims to synthesize current evidence regarding the safety of AFG in this unique patient population. Material and methods The review was conducted following the PRISMA-ScR guidelines. PubMed and Scopus databases were searched up to December 2024 using the terms "autologous fat grafting," "lipofilling," "head and neck cancer," and "oncologic safety." Eligible studies included clinical or experimental works reporting on AFG in HNC patients with oncologic outcome assessment. Exclusion criteria included purely aesthetic procedures and studies without relevance to oncologic safety. Data were extracted on study design, patient population, fat grafting technique, follow-up, and reported oncologic outcomes. Results Five key studies fulfilled the inclusion criteria: A multinational survey of surgeons (Fiedler et al., 2021), a retrospective cohort study of parotidectomy patients (Boschetti et al., 2023), a narrative review on craniofacial oncologic patients (Drochioi et al., 2019), a retrospective s

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

How we grade evidence
HumansHead and Neck NeoplasmsTransplantation, AutologousAdipose TissuePlastic Surgery Procedures

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research